Research output per year
Research output per year
Personal profile
Main research areas
- Development of rehabilitation forms for neuromuscular diseases
- New disease discovery
- Neuromuscular diseases - development of MR technics; natural history studies; development of animodels; development of treatments; investigate pathophysiology
- Characterize pheno-/ genotypes relations
- Develop outcome measures for follow-up and treatment of neuromuscular diseases
External positions
University of Copenhagen
2005 → …
Fingerprint
Dive into the research topics where John Vissing is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2-[18F] FDG PET/CT in Rapid Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report
Høj, A., Holm-Yildiz, S., Krag, T., Dejanovic, D., van Overeem Hansen, T., Dunø, M., Ørngreen, M. C., Vissing, J. & Løkken, N., Mar 2025, In: JIMD Reports. 66, 2, e12469.Research output: Contribution to journal › Journal article › Research › peer-review
-
276th ENMC workshop: recommendations on optimal diagnostic pathway and management strategy for patients with acute rhabdomyolysis worldwide. 15th-17th March 2024, Hoofddorp, The Netherlands
Kruijt, N., Laforet, P., Vissing, J., Bhai, S., Stemmerik, M. G., Kleefeld, F., Voermans, N. C. & 276th ENMC workshop participants, 30 Mar 2025, (E-pub ahead of print) In: Neuromuscular disorders : NMD. 50, p. 105344 105344.Research output: Contribution to journal › Journal article › Research › peer-review
-
281st ENMC international workshop: 2nd ENMC workshop on exercise training in muscle diseases; towards consensus-based recommendations on exercise prescription and outcome measures. Hoofddorp, The Netherlands, 4-6 October 2024
Voorn, E. L., Lucia, A., Vissing, J. & 281st ENMC workshop study group, 18 Feb 2025, (E-pub ahead of print) In: Neuromuscular disorders : NMD. 49, p. 105318 105318.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Nowak, R. J., Benatar, M., Ciafaloni, E., Howard, J. F., Leite, M. I., Utsugisawa, K., Vissing, J., Rojavin, M., Li, Q., Tang, F., Wu, Y., Rampal, N., Cheng, S. & MINT Investigators, 8 Apr 2025, (E-pub ahead of print) In: The New England journal of medicine. 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Biological biomarkers in muscle diseases relevant for follow-up and evaluation of treatment
Stemmerik, M. G., Tasca, G., Gilhus, N. E., Servais, L., Vicino, A., Maggi, L., Sansone, V. & Vissing, J., 3 Feb 2025, In: Brain : a journal of neurology. 148, 2, p. 363-375 13 p.Research output: Contribution to journal › Review › peer-review